BEXSERO® - Meningococcal Group B Vaccine (rDNA, component, adsorbed) - International Website
About BEXSERO for HCPs including indications, dosing, administration, immunogenicity, tolerability, and important safety information. Active immunization of individuals from 2 months of age or older against invasive meningococcal disease caused by Neisser
BEXSERO, Meningococcal Group B Vaccine (rDNA, component, adsorbed), meningococcal disease caused by Neisseria meningitidis group B, indications, dosing, administration, immunogenicity, tolerability, important safety information
Is this your site? Certify your site and update informations
